Prolactinoma Clinical Trial
— TNAPAOfficial title:
Prospective Randomized Clinical Study on Transsphenoidal or Dopamine Drugs Therapy Treat Non-invasive Prolactinoma
the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.
Status | Recruiting |
Enrollment | 394 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: non-invasive prolactionma Exclusion Criteria: invasive prolactioma |
Country | Name | City | State |
---|---|---|---|
China | Sun Yat-sen 5010 program | Guangzhou |
Lead Sponsor | Collaborator |
---|---|
First Affiliated Hospital, Sun Yat-Sen University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Endocrine remission rate | After intervention, blood prolactin normalization rate | five-year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03038308 -
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03400865 -
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
|
N/A | |
Completed |
NCT00481299 -
Insulin Resistance in Women With Prolactinoma
|
N/A | |
Terminated |
NCT04106531 -
Validation of a Quality of Life Metric "Prolac-10"
|
||
Completed |
NCT01504399 -
Rhinological Outcomes in Endonasal Pituitary Surgery
|
||
Recruiting |
NCT03474601 -
Seoul National University Pituitary Disease Cohort Study
|
||
Recruiting |
NCT04107480 -
PRolaCT - Three Prolactinoma RCTs
|
Phase 4 | |
Completed |
NCT00697814 -
Clomiphene in Males With Prolactinomas and Persistent Hypogonadism
|
Phase 2 | |
Completed |
NCT05236829 -
Exercise Capacity and Physical Activity Level in Prolactinoma Patients
|
||
Recruiting |
NCT03457389 -
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
|
N/A | |
Recruiting |
NCT01775332 -
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
|
N/A | |
Not yet recruiting |
NCT03717454 -
Dopamine D2 Receptors(D2R) Imaging in Prolactinomas
|
N/A | |
Recruiting |
NCT00001595 -
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
|